Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 36 results found. Search for [ generic drugs in Brazil ]

Results 1 to 21 of 36
BusinessToday.In
March 30, 2021
Biocon share price rose as much as 2.71 per cent to hit intraday high of Rs 406 on the BSE after the biopharma company signed pact with Libbs Farmaceutica to launch generic formulations in Brazil


BusinessToday.In
March 30, 2021
Shares of Nazara Technologies, Adani Transmission, IndusInd Bank, M&M, India Grid Trust, Manappuram Finance, PSU banks will be in focus in Tuesday's trading session


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


BusinessToday.In
June 23, 2020
COVID-19 vaccine latest news update: Herbal medicine company Patanjali Ayurved, on Tuesday, launched 'Coronil' and 'Swasari', its Ayurvedic medicines claiming to treat COVID-19 patients within 14 days


BusinessToday.In
June 22, 2020
COVID-19 vaccine latest news: Biotechnology and pharmaceutical firms comprising Moderna Inc, and AstraZeneca, have been accelerating the pace of their production, promising millions of supplies of their experimental vaccines before this year-end


PTI
October 25, 2019



PTI
September 2, 2019



PTI
April 29, 2019



PTI
April 23, 2019



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


Joe C Mathew
New Delhi, July 24, 2018
This declaration will set the tone of the policy direction in which global community will move to tackle the menace of TB.


PB Jayakumar
November 6, 2017
There was a time when the company was staring at bankruptcy and also there was a time it was contemplating huge acquisitions for growth with private equity support.


Niti Kiran
New Delhi, September 16, 2017
India is seeing a slump in drug exports since the beginning of the fiscal driven by a decline in the sale of Indian drugs in the US.


E. Kumar Sharma
New Delhi, June 10, 2017
Dr. Reddy's says it has a plan and a product pipeline to drive growth in spite of regulatory and other challenges. Can it pull it off?


by P.B. Jayakumar
Delhi, December 12, 2016
Torrent Pharmaceuticals was a late entrant to the US, but Samir Mehta has led it to fast-paced growth in that market.


By David Singh Grewal and Amy Kapczynski
Delhi, December 28, 2015
Yale Law School's associate professor David Singh Grewal (right), a specialist in IP law and biotechnology and Professor Amy Kapczynski explain how to make drugs-for-all a national priority.


E Kumar Sharma
December 18, 2015
Till end of November, over 170 inspections were held in India as against over 70 inspection and certainly much less than 100 conducted five years ago by the US regulator in India.


PB Jayakumar
December 25, 2015
Developed markets together now contribute 48% to Lupin's revenue (the bulk, no doubt, coming from the US) and emerging markets another 19%, while the domestic market's share has shrunk to 26 per cent from 31 per cent five years ago.


PB Jayakumar
October 9, 2015
Mylan CEO Heather Bresch says India has been doing a pretty good job with its tax-free development zones. Your CSR model is something the rest of the world should follow. It is a great thing to give back to the country, especially when you are developing.


PAGES 1 OF 2  12